Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention
Dibyendu Dutta, Amandeep Aujla, Bettina M. Knoll, et al.
British Journal of Haematology (2019) Vol. 188, Iss. 4, pp. 488-493
Open Access | Times Cited: 21

Showing 21 citing articles:

Effect of Blueberry Anthocyanin-Rich Extracts on Peripheral and Hippocampal Antioxidant Defensiveness: The Analysis of the Serum Fatty Acid Species and Gut Microbiota Profile
Xu Si, Jinfeng Bi, Qinqin Chen, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 12, pp. 3658-3666
Closed Access | Times Cited: 65
Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions
Victoria Bell, Theodoros Varzakas, Θεοδώρα Ψαλτοπούλου, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 258-258
Open Access | Times Cited: 14
Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events
Tim Jang, Maria Poplawska, Emanuela Cimpeanu, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Managing gastrointestinal challenges: Diarrhea in sickle cell anemia
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu
Medicine (2024) Vol. 103, Iss. 18, pp. e38075-e38075
Open Access | Times Cited: 5
The gut microbiome in sickle cell disease: Characterization and potential implications
Hassan Brim, James G. Taylor, Muneer Abbas, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255956-e0255956
Open Access | Times Cited: 31
Understanding the hepatoxicity of inorganic mercury through guts: Perturbance to gut microbiota, alteration of gut-liver axis related metabolites and damage to gut integrity
Xiaoying Lin, Wei Zhang, Lina He, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 225, pp. 112791-112791
Open Access | Times Cited: 22
Microbial gut evaluation in an angolan paediatric population with sickle cell disease
Mariana Delgadinho, Catarina Ginete, Brígida Santos, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 21, pp. 5360-5368
Open Access | Times Cited: 15
Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications
Tarimoboere Agbalalah, Doofan Bur, Ezinne Janefrances Nwonu, et al.
Anemia (2024) Vol. 2024, pp. 1-8
Open Access | Times Cited: 2
Rifaximin on intestinally‐related pathologic changes in sickle cell disease
Dibyendu Dutta, Kelvin Li, Barbara A. Methé, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 4
Open Access | Times Cited: 15
The relationship between nutrition, gut dysbiosis, and pediatric sickle cell pain outcomes: A pilot study
Chinenye R. Dike, Corrine Hanson, H. Dele Davies, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 7
Open Access | Times Cited: 5
Gene Therapy for Hemoglobinopathies
Maria Rosa Lidonnici, Samantha Scaramuzza, Giuliana Ferrari
Human Gene Therapy (2023) Vol. 34, Iss. 17-18, pp. 793-807
Closed Access | Times Cited: 5
Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect
Mariana Delgadinho, Luísa Veiga, Catarina Ginete, et al.
Annals of Hematology (2023) Vol. 103, Iss. 2, pp. 409-419
Open Access | Times Cited: 5
Intestinal pathophysiological abnormalities in steady state and after vaso‐occlusive crisis in murine sickle cell disease
Maria Poplawska, Dibyendu Dutta, Manjunath Jayaram, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 3, pp. 777-780
Open Access | Times Cited: 11
How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia
Mariana Delgadinho, Catarina Ginete, Brígida Santos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9061-9061
Open Access | Times Cited: 6
Gut microbiota dysbiosis alters chronic pain behaviors in a humanized transgenic mouse model of sickle cell disease
Yavnika Kashyap, Zaijie Jim Wang
Pain (2023)
Closed Access | Times Cited: 2
Antibiotics to modify sickle cell disease vaso-occlusive crisis?
Connor Stewart, Tim Jang, George Mo, et al.
Blood Reviews (2021) Vol. 50, pp. 100867-100867
Closed Access | Times Cited: 4
GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell Disease
Elio Haroun, Seah H. Lim, Dibyendu Dutta
Medicina (2024) Vol. 60, Iss. 10, pp. 1581-1581
Open Access
Very low incidence of <i>Clostridioides difficile</i> infection in pediatric sickle cell disease patients
Philip Lee, Arpan A. Sinha, Vijaya L Soma, et al.
Haematologica (2020) Vol. 106, Iss. 5, pp. 1489-1490
Open Access | Times Cited: 3
Microbiome in sickle cell disease: Pathophysiology and therapeutic insights
Chhedi Lal Gupta, Nagaraj Jaganathasamy, Manisha Madkaikar
British Journal of Haematology (2024)
Closed Access
Antibiotic use in adults during sickle cell vaso‐occlusive crisis: Is it time for a controlled trial?
Tim Jang, George Mo, Connor Stewart, et al.
British Journal of Haematology (2021) Vol. 193, Iss. 6, pp. 1281-1283
Closed Access | Times Cited: 2
Unveiling the Risk Factors of Clostridioides difficile Infection in Children; A Multicenter Retrospective Case-control Study in the Eastern Region, Saudi Arabia
Taghrid Kharboush, Fatima Abu Deeb
The Egyptian Journal of Medical Microbiology (2023) Vol. 32, Iss. 1, pp. 157-162
Open Access
Page 1

Scroll to top